Press Release - Kyoto Breast Cancer Research Network (KBCRN)

Press Release

A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy plus Palbociclib versus Hormonal Therapy plus Placebo in Women with Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

(04/15/2022)

Kyoto Breast Cancer Research Network (KBCRN)
Announcing change of company name

(04/27/2015)

KBCCC 2014 Poster Design Invitation

(12/26/2012)

KBCCC 2011 Introduction Article

(06/24/2011)

KBCCC 2011 Poster Design Invitation

(05/11/2010)

KBCCC Handbook Publication

(04/23/2010)

KBCCC 2009 International Convention

(04/09/2009)

Get Adobe Reader

You will need Adobe Reader to view and print PDF documents. Download a free copy of the latest version of Adobe Reader.

KBCRN